Bio Blast Pharma Prices Initial Public Offering of $35,200,000 of Ordinary Shares Jul 30, 2014 06:33PM
Maxwell (MXWL) Risk-Reward Favorable into Q2 Report on Recent Pullback, FY15 Bus Read Through Jul 30, 2014 02:15PM
Roth Boosts PT on Regeneron (REGN) to $399 Following ODYSSEY Phase III Data, EYLEA Approval Jul 30, 2014 10:03AM
Orbite Announces Second Quarter and Six Month 2014 Results and Updates Construction of HPA Facility Jul 30, 2014 07:57AM
Pretivm Closes US$60 Million Primary and Secondary Common Share Offering Jul 29, 2014 08:54AM
View Older Stories

Jul 29, 2014 07:30AM ContraFect Announces Pricing of Its Initial Public Offering
Jul 28, 2014 02:07PM Roth Capital Comments on Pharmacyclics (PCYC) Following Expanded IMBRUVICA Coverage; Affirms 'Buy' Rating
Jul 28, 2014 10:41AM Roth Affirms 'Buy' Rating on Stemline (STML); Comments on SL-401 News
Jul 28, 2014 09:30AM Pre-Open Stock Movers 7/28: (FDO) (XGTI) (TRLA) Higher; (ACRX) (HZNP) (Z) Lower (more...)
Jul 28, 2014 08:00AM CymaBay Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 28, 2014 07:00AM Roth Capital Upgrades Prosensa (RNA) to Buy
Jul 28, 2014 07:00AM xG Technology Awarded Subcontract by CACI on $497 Million Multiple-Award Contract to Provide Communications and Networking Services to U.S. Army
Jul 25, 2014 12:33PM Roth Highlights Two Takeaways from SolarCity's (SCTY) ABS Offering; Maintains 'Buy' Rating
Jul 25, 2014 09:14AM Mines Management (MGN) Plans 4,000 Units Offering
Jul 25, 2014 08:58AM Roth Positive on Pharmacyclics (PCYC) Following CHMP Recommendation of Imbruvica
Jul 25, 2014 07:13AM Applied Genetic Technologies (AGTC) Prices 2M Common Offering at $15/Share
Jul 24, 2014 07:05PM AGTC Announces Pricing of Public Offering
Jul 24, 2014 07:05PM AGTC Announces Pricing of Public Offering
Jul 24, 2014 10:43AM Notable Analyst Rating Changes 07/24: (RKUS) (UIS) (SEIC) Upgraded; (ANGI) (QCOM) (BA) Downgraded
Jul 24, 2014 06:45AM Roth Capital Starts CorMedix (CRMD) at Buy
Jul 23, 2014 01:55PM Roth Sees Significant Advantages to TG Therapeutics' (TGTX) TGR-1202 vs. Gilead's (GILD) Zydelig; Reiterates 'Focus Pick' Rating
Jul 23, 2014 08:57AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital
Jul 22, 2014 02:06PM NHLBI Trial Choice Validates Cytori (CYTX) as Top Stem Cell Player - Roth Capital
Jul 22, 2014 11:02AM Notable Analyst Rating Changes 07/22: (AGN) (RLGY) (FANG) Upgraded; (AMZN) (STI) (MTDR) Downgraded
Jul 22, 2014 10:17AM Pretivm Prices Offering of Common Shares
Jul 22, 2014 10:07AM Roth Capital Comments on Ligand (LGND) Following SAGE-547 Update
Jul 22, 2014 09:12AM Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News
Jul 22, 2014 08:43AM Roth Capital Upgrades Ultra Clean (UCTT) to Buy
Jul 22, 2014 08:14AM CymaBay Therapeutics (CBAY) Prices 4M Follow-On at $5.50/Share
Jul 22, 2014 08:00AM CymaBay Therapeutics Announces Pricing of Public Offering of Common Stock
Jul 22, 2014 06:50AM Roth Capital Upgrades Diamondback Energy (FANG) to Buy
Jul 22, 2014 06:27AM Roth Capital Boosts Price Target on TG Therapeutics (TGTX) to $25 on Prelim. TG-1101 Phase 1 Data
Jul 21, 2014 12:19PM IRADIMED CORPORATION Announces Closing of Initial Public Offering
Jul 21, 2014 08:31AM 3rd Annual Gateway Conference to Showcase More Than 60 High-Growth Public Companies in San Francisco on September 4
Jul 18, 2014 10:56AM Roth Encouraged by Progress with Supinoxin; Maintains 'Buy Rating on Rexahn Pharma (RNN)
Jul 18, 2014 10:28AM Notable Analyst Rating Changes 07/18: (BC) (AMH) (PLXS) Upgraded; (RP) (AMD) (NUS) Downgraded
Jul 18, 2014 09:43AM Roth Capital Affirms Regeneron (REGN) at 'Buy'; Comments on Eylea Phase III VIVID-DME Two-Year Data
Jul 18, 2014 09:22AM Pre-Open Stock Movers 7/18: (ICLD) (GTIV) (SWKS) (GOOG) Higher; (RP) (NQ) (AMD) Lower (more...)
Jul 18, 2014 07:54AM Roth Capital Sees Prelim. Q2 Revenue Numbers from Ligand (LGND) as Just the Beginning of More Success to Come
Jul 18, 2014 06:52AM Roth Capital Starts PEDEVCO Corp (PED) at Buy
Jul 18, 2014 06:50AM Roth Capital Starts Nimble Storage (NMBL) at Buy
Jul 17, 2014 03:28PM Plug Power Shipments/Bookings Going as Expected; Roth Issues Commentary Following Analyst Meetings
Jul 17, 2014 06:51AM CymaBay Therapeutics Announces Proposed Offering of Common Stock
Jul 16, 2014 12:13PM's Hot Lunchtime Reads 07/16: (AAPL) (MCP) (MNGA) (YHOO)
Jul 16, 2014 10:54AM Roth Capital Encouraged by Removal of CTP-354 Clinical Hold; Has Concert Pharma (CNCE) at 'Buy'
Jul 16, 2014 08:33AM IRadimed Corporation Announces Pricing of Initial Public Offering
Jul 15, 2014 09:56AM Roth Capital Affirms Peregrine Pharma (PPHM) at 'Buy'; Remains Encouraged by Progress in FY14
Jul 15, 2014 09:27AM No Major N-T Impact Expected on Solars Following WTO Statement on U.S. Antidumping Duties - Roth (SCTY) (JASO) (TSL) (YGE)
Jul 15, 2014 07:00AM xG Technology to Showcase Innovative Private Broadband Wireless Network Solution for Public Safety Communications at APCO 2014 Event
Jul 11, 2014 08:35AM Roth Affirms Verastem (VSTM) at 'Buy'; Encouraged by VS-6063's Potential in Mesothelioma, Ovarian Cancer
Jul 11, 2014 08:23AM Tonix Pharmaceuticals (TNXP) Enters 657K Direct Placement at $11.90/Share
Jul 11, 2014 08:20AM Tonix Pharmaceuticals Announces Registered Direct Offering of $7.8 Million
Jul 11, 2014 08:12AM Roth Capital Downgrades Golden Minerals Company (AUMN) to Neutral
Jul 10, 2014 12:09PM's Hot Lunchtime Reads 07/10: (CYNK) (MSFT) (SRPT) (CYTK)
Jul 10, 2014 11:14AM Roth Capital Keeps Cytokinetics (CYTK) at 'Buy' Following Recent BENEFIT-ALS Update
View Older Stories